43rd Annual J.P. Morgan Healthcare Conference

01/15/2025 | 3:45pm PST / 6:45pm EST

Listen to the webcast

Events & Presentations

View all events

Financial Reports and Filings

Date Filing Title Downloads
01/15/2025 8-K Report of unscheduled material events or corporate event RTF XLS PDF HTML XBRL
01/02/2025 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
View all filings

Latest News

Myriad Genetics Introduces Online Prenatal Genetic Testing Resource Thumbnail

Myriad Genetics Introduces Online Prenatal Genetic Testing Resource

Jan 23, 2025 | Products

Read more
Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology Thumbnail

Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology

Jan 21, 2025 | Products | Corporate

Read more
Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2024 Financial Results and Introduces Full Year 2025 Financial Guidance Thumbnail

Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2024 Financial Results and Introduces Full Year 2025 Financial Guidance

Jan 15, 2025 | Financial | Corporate

Read more
View all news releases

Quality, Innovation and Corporate Responsibility Report

Myriad Genetics has a strong commitment to operational excellence, innovation and being a good corporate partner. Our dedication to these important issues serve as the foundation to achieving our mission of advancing health and well-being for all.

Learn more about the actions we’re taking in quality, innovation, and corporate responsibility.

Read our QICR report
“Quality, innovation and corporate responsibility are at the heart of what we do at Myriad Genetics. This report reflects our progress on how we are making genetic testing more accessible, helping patients take more control of their health, and enabling providers to better prevent and treat disease."

— Paul J. Diaz
President and CEO, Myriad Genetics

Quality, Innovation and Corporate Responsibility Report

Myriad Genetics has a strong commitment to operational excellence, innovation and being a good corporate partner. Our dedication to these important issues serve as the foundation to achieving our mission of advancing health and well-being for all.

Learn more about the actions we’re taking in quality, innovation, and corporate responsibility.

Read our QICR report
“Quality, innovation and corporate responsibility are at the heart of what we do at Myriad Genetics. This report reflects our progress on how we are making genetic testing more accessible, helping patients take more control of their health, and enabling providers to better prevent and treat disease."

— Paul J. Diaz
President and CEO, Myriad Genetics